Patterns and predictors of anxiety and depression symptom trajectories in patients diagnosed with primary brain tumors
Alayna E. Ernster(Wake Forest University), Ashley Ghiaseddin(University of Florida), Kelsey C. Bacharz(University of Florida), Annie Allen(University of Florida), Kaitlyn Melnick(University of Florida), Deborah Sampson(University of Florida), Anjelica Body(University of Florida), Phuong Deleyrolle(University of Florida), Deidre Pereira(University of Florida), Duane A. Mitchell(University of Florida), Maryam Rahman(University of Florida), David D. Tran(University of Florida), Sandra C. Yan(University of Florida), Jennifer St. Clair(University of Florida)
Cited by 9
Related Papers
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
|Journal of Translational Medicine|2018|540
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma
|JAMA Oncology|2022|411
CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas
|Proceedings of the National Academy of Sciences|2019|330
An NAD <sup>+</sup> -dependent transcriptional program governs self-renewal and radiation resistance in glioblastoma
|Proceedings of the National Academy of Sciences|2016|134
Tumor Treating Fields in the Management of Patients with Malignant Gliomas
|Current Treatment Options in Oncology|2020|101